| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.00054 | 1 |